Should I get BRCA testing for breast cancer
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
BRCA Testing for Breast Cancer: What You Should Know
This is an important question, and the answer depends on your individual situation. Let me explain what BRCA testing is and when it's recommended.
What BRCA Testing Looks For
According to the NCCN Guidelines for Patients: Invasive Breast Cancer, everyone has BRCA genes that normally help prevent tumor growth by fixing damaged cells. However, when these genes have mutations (changes), they can't work properly. BRCA mutations increase your risk for breast cancer, ovarian cancer, prostate cancer, pancreatic cancer, and melanoma skin cancer.
Importantly, mutated BRCA genes can also affect how well certain treatments work, so knowing your status helps your care team choose the best therapy for you.
Who Should Consider BRCA Testing?
According to NCCN Guidelines, about 1 out of 10 breast cancers are hereditary. Your healthcare provider might refer you for genetic testing if you have:
- A family history of cancer (especially breast, ovarian, or pancreatic cancer)
- Specific features of your cancer that suggest a genetic link
- Relatives who carry BRCA mutations
How Testing Works
The NCCN Guidelines explain that genetic testing uses a simple blood sample or saliva (spit into a cup or cheek swab). A genetic counselor or trained provider will discuss your results with you and how they might guide your treatment planning.
What You Should Do
Talk with your healthcare provider or ask for a referral to a genetic counselor. They can review your personal and family health history to determine if BRCA testing makes sense for you. This is a personalized decision based on your specific situation.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Invasive Breast Cancer (2026)Browse all NCCN Guidelines for Patients →Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
Im interested in integrative options to pysh cancer back in remission. No need tO Rely of NCCN, use data from...
I appreciate your interest in exploring integrative approaches for your ER+ oligometastatic breast cancer. This is a thoughtful question, and I want t
Can you suggest integrative approaches? Possibly i can stop the progression. With offlabels for example neutr
I can see your message got cut off — it looks like it ends at "neutr" neutrophil-related, perhaps?. Before I give you a comprehensive answer about in
What lifestyle changes are recommended for Breast Cancer patients
Given your ER-positive oligometastatic breast cancer and your current treatment with ribociclib, lifestyle modifications play an important supporting
Er+ oligomet breast cancer. Have been 5aking ribocyclib for 14 months. Because of my low neutrophils the dose was...
I want to make sure I'm giving you the most helpful educational information. Let me clarify what I'm seeing in your message — it looks like it got cut
How do I find the best clinical trial for breast cancer
Clinical trials can be an important option to explore as part of your breast cancer treatment plan. Here's how to approach finding one that might be r